Delphia (Usa) Inc. Ab Cellera Biologics Inc. Transaction History

Delphia (Usa) Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $28,127 - $43,080	-2,967 Reduced 13.96%	18,282 $185,000
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $266,698 - $396,569	-28,989 Reduced 57.7%	21,249 $210,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $193,850 - $360,928	33,890 Added 207.3%	50,238 $535,000
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $121,956 - $231,160	16,348 New	16,348 $159,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.